The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPressure Tech Regulatory News (PRES)

Share Price Information for Pressure Tech (PRES)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 37.50
Bid: 36.00
Ask: 39.00
Change: 0.00 (0.00%)
Spread: 3.00 (8.333%)
Open: 37.50
High: 37.50
Low: 37.50
Prev. Close: 37.50
PRES Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results 2009

8 Jun 2009 07:00

RNS Number : 4923T
Pressure Technologies PLC
08 June 2009
 



INTERIM RESULTS 2009

Pressure Technologies plc ("Pressure Technologies" or the "Group") is pleased to announce its interim results for the six months to 28 March 2009.

Financials:

Revenue increased to £12.7 million (2008: £11.7 million)

Operating profit, before one-off costs and exchange rate loss, of £2.6 million (2008: £2.1 million)

Pre-tax profit unchanged at £2.4 million 

Basic earnings per share of 15.5p (2008: 15.0p)

Strong, ungeared balance sheet - cash at bank £6.1 million (2008: £3.0 million)

Progressive dividend policy - interim dividend at 2.2p per share (2008: 2.0p) - up 10%

Key Points:

Substantial order book of £21 million (2008: £18 million), despite weakening markets

Results for full year expected to be broadly in line with market expectations

Diversification strategy continues: 

 New product and service developments progressed

 In-house M&A specialist appointed since half year end

Prospects:

 Medium to long term prospects remain strong, despite short term issues affecting 2010 

 Pipeline of open quotations in core business and interest in biogas products very healthy

 Acquisitions and new product development providing exciting growth opportunities

Richard Shacklady, Chairman of Pressure Technologies, said: "I am pleased to report that the Group is displaying its resilience and has achieved a solid set of results for the first half of the current financial year, despite the global economic crisis and some weakening in our key markets."

For further information, please contact:

Pressure Technologies plc

John Hayward, Chief Executive

James Lister, Group Finance Director

Tel: 0114 242 7500

www.pressuretechnologies.co.uk

Rawlings Financial PR Limited

Catriona Valentine

Keeley Clarke

Tel: 01653 618 016

www.rawlingsfinancial.co.uk

Brewin Dolphin Investment Banking

Neil Baldwin

Sandy Fraser

Tel: 0845 270 8610

Tel: 0845 213 2110

Company description:

Pressure Technologies is the holding company for Chesterfield Special Cylinders Limited ("CSC"). CSC designs, manufactures and offers retesting and refurbishment services for a range of speciality high pressure, seamless steel gas cylinders for global energy and defence markets. The business has been conducted under the "Chesterfield" brand which is a long established name in the cylinders and specialised pressure vessel market.

Chesterfield BioGas Limited ("Chesterfield BioGas"), an operating division of Pressure Technologies, formed in November 2008 following the signing of a co-operation agreement with Greenlane® Biogas Limited, the world leader in biogas upgrading from raw biogas to vehicle quality fuel, gives Pressure Technologies exclusive rights to market Greenlane® equipment in the UK and Eire. Chesterfield BioGas will provide turnkey solutions for the cleaning, storage and dispensing of biomethane, produced from waste water treatment and anaerobic digestion of organic waste.

Chairman's Statement

I am pleased to report that the Group is displaying its resilience and has achieved a solid set of results for the first half of the current financial year, despite the global economic crisis and some weakening in our key markets.

Financial highlights

In the six months to 28 March 2009, revenue increased by 9% to £12.7 million (2008: £11.7 million). Whilst volumes have remained at the same level as the first half of last year, underlying operating profits at £2.6 million (2008: £2.1 million) benefited from a favourable product mix.

At a reported level, the results were impacted by one-off costs incurred in the establishment of Chesterfield BioGas of £0.1 million and an IAS 39 exchange loss of £0.1 million (2008: gain £0.2 million). Overall, operating profit at a reported level improved marginally to £2.4 million (2008: £2.3 million). Profit before taxation remained unchanged at £2.4 million. Earnings per share rose to 15.5p (2008: 15.0p).

Given our strong balance sheet, the Board is pleased to announce an increase in the interim dividend to 2.2 pence per share (2008: 2.0 pence) in line with our progressive dividend policy. This will be paid on 10 August 2009 to shareholders on the register at the close of business on 10 July 2009. The ex-dividend date will be 8 July 2009. 

Review of operations

Trading in our main market, the oil and gas sector, was broadly in line with the corresponding half year period in 2008 with sales in this sector representing around 79% of total revenues. It is pleasing to note that our two major customers now account for less than 70% of total Group revenues (2008: 74%), as business with other customers has grown successfully.

Recent weakening of the oil and gas market has had no impact on orders for delivery in the current financial year. Whilst our order book remains substantial, there is no doubt that order visibility in the oil and gas sector has been reduced, with lead times shortening as customers delay decisions to the last possible moment. 

Since the half year end, we failed to secure £4 million of oil and gas contracts, relating to the 2010 financial year. This was due to protectionist policies in South East Asia. We expect this loss of business in 2010 to be partially offset by contract wins in our new biogas division.

Our activity in the export defence markets increased significantly with the value of orders delivered in the period under review rising by 50%. Negotiations on the next phase of the Astute submarine programme were advanced, although the UK defence market generally remained subdued. Sales to the aerospace sector also improved substantially (up 25%) but there was a distinct reduction in future orders placed during the first half, as a result of UK defence budget cuts on spares and cutbacks in executive jet building. 

The industrial gas trailer and refurbishment business continues to develop positively. Sales doubled in the first half, when compared with the corresponding period in 2008, in line with our internal budgets. We continue to target new customers in this sector and expect further improvement in 2010.

Since the half year end, we have appointed a new business manager to focus on developing our small cylinder business unit, which includes aerospace, industrial gases, factored products and retest and reconditioning. 

Our newly established compressed natural gas business, Chesterfield BioGas, was very active in the period under review. In November 2008, the Group secured an exclusive licence agreement with Greenlane® Biogas Limited for the manufacture and distribution of biogas upgrade equipment in the UK and Eire. Projects totalling over £10 million have since been identified. These are for delivery between 2010 and 2012 and have reached varying stages of the quotation process.

Pressure Technologies is flexible and responsive and we were able to react quickly to the changing needs of our customers and the move to shorter lead times experienced during the period. We are also responding rapidly to changes in market conditions. Further manufacturing efficiencies have been made since the half year end, with a reduction in headcount of six in April 2009, and the Group is investing in additional sales personnel, focused on new business opportunities in ultra large and small cylinders, in the second half.

Strategy

Our strategy to penetrate key growth sectors, notably global energy and high pressure gases markets, and to establish a presence in new niche markets, acquiring businesses which offer synergistic benefits in related niche sectors, is progressing.

In March 2009, we recruited an experienced M&A specialist to support the Board in its diversification by acquisition strategy.

The Group is committed to its R&D programmes. We are making real headway in the development of a composite cylinder product and have made further progress on our in-situ cylinder testing service, which we now believe has wider applications than just oil and gas as originally envisaged.

People

We continued to strengthen our technical and second tier specialist management, appointing an additional designer and a non-destructive testing specialist in CSC and a gas engineer in Chesterfield BioGas. It is pleasing to note the ongoing commitment of all our employees to vocational improvement training programmes, as well as College and University courses.

Prospects

The Group's results for the full year ending 3 October 2009 are expected to be broadly in line with market forecasts.

We entered the second half of the financial year with a forward order book, stretching through 2009 and into 2010, of £21 million (2008: £18 million). The pipeline of open quotations for worldwide projects in our core business and interest in the Group's new biogas products are very healthy. However, due to competitive pressures in the oil and gas sector, and the reduced order visibility, the Board is prudently anticipating that revenues for 2010 are likely to be slightly lower than those of the current financial year.

Despite the short term issues, the Directors are confident that the Group's prospects in the medium to long term remain strong.

Richard L Shacklady

Chairman

8 June 2009

Condensed Consolidated Interim Income Statement

Unaudited

Six months

ended

28 March

2009

Unaudited

Six months

ended

29 March

2008

Audited

Year

ended

27 September 2008

Note

£'000

£'000

£'000

Revenue 

2

12,735

11,674

23,660

Cost of sales

(8,789)

(7,964)

(16,150)

Gross profit

3,946

3,710

7,510

Administration expenses

(1,568)

(1,363)

(2,578)

Operating profit

2,378

2,347

4,932

Finance income

74

88

155

Finance cost

(8)

(13)

(41)

Profit before taxation

2,444

2,422

5,046

Taxation

3

(685)

(719)

(1,465)

Profit for the financial period

1,759

1,703

3,581

Earnings per share - basic

4

15.5p

15.0p

31.6p

Earnings per share - diluted

4

15.5p

15.0p

31.5p

Condensed Consolidated Balance Sheet

Unaudited

28 March

2009

Unaudited

29 March

2008

 Audited

27 September

2008

£'000

£'000

£'000

 

 

Non-current assets

Property, plant and equipment

2,146

1,898

2,043

Deferred tax asset

80

62

76

2,226

1,960

2,119

Current assets

Inventories

7,284

5,754

6,527

Trade and other receivables

4,802

6,624

3,125

Derivative financial instruments

55

322

110

Cash and cash equivalents

6,100

3,025

6,091

18,241

15,725

15,853

Total assets

20,467

17,685

17,972

Current liabilities

Trade and other payables

(6,200)

(6,208)

(4,731)

Current portion of long-term borrowings

(80)

(80)

(80)

Current tax liabilities

(704)

(1,016)

(846)

(6,984)

(7,304)

(5,657)

Non-current liabilities

Other payables

(618)

(336)

(695)

Long-term borrowings

(120)

(200)

(160)

Deferred tax liabilities

(272)

(341)

(293)

(1,010)

(877)

(1,148)

 

Total liabilities

(7,994)

(8,181)

(6,805)

Net assets

12,473

9,504

11,167

Equity

Share capital

567

567

567

Share premium account

5,341

5,341

5,341

Retained earnings

6,565

3,596

5,259

Total equity

12,473

9,504

11,167

Condensed Consolidated Interim Cash Flow Statement

Unaudited

Six months

ended

28 March

2009

Unaudited

Six months ended

29 March

2008

Audited

Year

ended

27 September

2008

£'000

£'000

£'000

Cash flows from operating activities

Profit after taxation

1,759

1,703

3,581

Adjustments for:

Depreciation

114

88

200

Finance income - net

(66)

(75)

(114)

Profit on disposal of property, plant and equipment

-

(19)

(19)

Gain on early repayment of deferred consideration

(20)

-

-

Share option costs

8

6

17

Taxation expense recognised in income statement

685

719

1,465

Loss/(gain) on derivative financial instruments

55

(244)

(32)

Increase in inventories

(757)

(1,204)

(1,977)

(Increase)/decrease in trade and other receivables

(1,677)

(3,469)

30

Increase/(decrease) in trade and other payables

1,519

860

(542)

Increase/(decrease) in non-current other payables

15

(112)

272

Cash generated from/(used for) operations

1,635

(1,747)

2,881

Finance costs paid

(8)

(13)

(41)

Income tax paid

(852)

-

(977)

Net cash from/(used for) operating activities

775

(1,760)

1,863

Cash flows from investing activities

Finance income received

74

88

155

Purchase of property, plant and equipment

(217)

(294)

(551)

Proceeds from sale of equipment

-

101

101

Payment of deferred consideration

(130)

-

(100)

Net cash flow used in investing activities

(273)

(105)

(395)

Cash flows from financing activities

Financing

Repayment of borrowings

(40)

(40)

(80)

Dividends paid

(453)

-

(227)

Net cash used for financing activities

(493)

(40)

(307)

Net increase/(decrease) in cash and cash equivalents

9

(1,905)

1,161

Cash and cash equivalents at beginning of period

6,091

4,930

4,930

Cash and cash equivalents at end of period

6,100

3,025

6,091

Notes to the Condensed Consolidated Interim Financial Statements

1. Basis of preparation

The Group's interim results for the six month period ended 28 March 2009 are prepared in accordance with the Group's accounting policies which are based on the recognition and measurement principles of International Financial Reporting Standards ("IFRS") as adopted by the EU and effective, or expected to be adopted and effective, at 3 October 2009. The principal accounting policies of the Group have remained unchanged from those set out in the Group's 2008 annual report and financial statements. As permitted, this interim report has been prepared in accordance with the AIM rules and not in accordance with IAS34 "Interim financial reporting".

These interim results do not constitute full statutory accounts within the meaning of section 240(5) of the Companies Act 1985 and are unaudited. The unaudited interim financial statements were approved by the Board of Directors on 8 June 2009. The interim financial statements have been reviewed by the company's auditors. A copy of the auditor's review report is attached to this interim report.

The consolidated financial statements are prepared under the historical cost convention as modified to include the revaluation of financial instruments. The statutory accounts for the year ended 27 September 2008, which were prepared under IFRS, have been filed with the Registrar of Companies. These statutory accounts carried an unqualified auditor's report and did not contain a statement under either Section 237(2) or (3) of the Companies Act 1985.

2. Segmental analysis

Revenue by destination

Unaudited

Six months

ended

28 March

2009

Unaudited

Six months

ended

29 March

2008

Audited

Year

ended

27 September

2008

£'000

£'000

£'000

United Kingdom

3,761

1,642

2,770

Europe

6

 730

 2,134

Rest of World

8,968

9,302

18,756

12,735

11,674

23,660

All turnover originates in the United Kingdom.

3. Taxation

Unaudited

Six months

ended

28 March

2009

Unaudited

Six months

ended

29 March 

2008

Audited

Year

ended

27 September

2008

£'000

£'000

£'000

Current tax 

710

654

1,461

Deferred taxation

(25)

65

4

Taxation charged to the income statement

685

719

1,465

4. Earnings per ordinary share

The calculation of the basic earnings per share is based on the earnings attributable to ordinary shareholders divided by the weighted average number of shares in issue during the year.

The calculation of diluted earnings per share is based on the basic earnings per share, adjusted to allow for the issue of shares on the assumed conversion of all dilutive options.

Unaudited

Six months

ended

28 March

2009

Unaudited

Six months

ended

29 March

2008

Audited

Year

ended

27 September

2008

£'000

£'000

£'000

Profit after tax

1,759

1,703

3,581

Number of shares

Number of shares

Number of

shares

Weighted average number of shares in issue (used for basic earnings per share)

11,333,620

11,333,620

11,333,620

Dilutive effect of options issued 30 November 2007

47,635

39,465

47,958

Diluted weighted average number of shares (used for diluted earnings per share)

11,381,255

11,373,085

11,381,578

Earnings per share - basic

15.5p

15.0p

31.6p

Earnings per share - diluted

15.5p

15.0p

31.5p

5. Dividends

The final dividend for the period to 27 September 2008 of 4.0p per share was paid on 12 March 2009.

An interim dividend of 2.2p per share will be paid on 10 August 2009 to shareholders on the register at the close of business on 10 July 2009.

6. Availability of Interim Report

A copy of the Interim Report will be sent to shareholders shortly, and will be available on the Company's website: www.pressuretechnologies.co.uk.

  Independent review report to Pressure Technologies plc

Introduction

We have been engaged by the company to review the condensed set of financial statements in the interim report for the six months ended 28 March 2009 which comprises of the Condensed Consolidated Interim Income Statement, Condensed Consolidated Balance Sheet, Condensed Consolidated Interim Cash Flow Statement and the Notes to the Condensed Consolidated Interim Financial Statements. We have read the other information contained in the interim report which comprises only of the Chairman's statement and considered whether it contains any apparent misstatements or material inconsistencies with the financial information.

This report is made solely to the company in accordance with guidance contained in ISRE (UK and Ireland) 2410, "Review of Interim Financial Information performed by the Independent Auditor of the Entity". Our review work has been undertaken so that we might state to the company those matters we are required to state to them in a review report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company, for our review work, for this report, or for the conclusion we have formed.

Directors' responsibilities

The interim financial report is the responsibility of, and has been approved by, the directors. The directors are responsible for preparing the interim report.

The accounting policies are consistent with those that the directors intend to use in the next annual financial statements.

Our responsibility

Our responsibility is to express to the Company a conclusion on the condensed set of financial statements in the interim report based on our review.

Scope of review

We conducted our review in accordance with International Standard on Review Engagements (UK and Ireland) 2410, "Review of Interim Financial Information Performed by the Independent Auditor of the Entity" issued by the Auditing Practices Board for use in the United Kingdom. A review of interim financial information consists of making enquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with International Standards on Auditing (UK and Ireland) and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.

Conclusion

Based on our review, nothing has come to our attention that causes us to believe that the condensed set of financial statements in the interim report for the six months ended 28 March 2009 is not prepared, in all material respects, in accordance with International Accounting Standards as adopted by the European Union and in accordance with the basis of accounting described in note 1.

Grant Thornton UK LLP

Chartered Accountants

BirminghamEngland

8 June 2009

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR FAMRTMMAMBRL
Date   Source Headline
21st Mar 202412:10 pmRNSResults of 2024 Annual General Meeting
14th Mar 20247:00 amRNSContract Placements and Update on Sale of PMC
14th Feb 20247:00 amRNSNotice of 2024 Annual General Meeting
30th Jan 20247:00 amRNS2023 Full-Year Results
16th Nov 20237:00 amRNSDebt Refinancing and Grant of Warrants
24th Oct 20237:00 amRNSDebt Refinancing - Agreement in Principle
9th Oct 20239:28 amRNSHolding(s) in Company
5th Oct 20233:56 pmRNSHolding(s) in Company
5th Oct 20233:52 pmRNSHolding(s) in Company
5th Oct 20232:38 pmRNSHolding(s) in Company
4th Oct 20233:10 pmRNSHolding(s) in Company
3rd Oct 20237:00 amRNSPost-Close Update
11th Aug 20232:24 pmRNSHolding(s) in Company
27th Jun 20237:00 amRNS2023 Interim Results
13th Jun 202311:40 amRNSResult of General Meeting
26th May 202312:02 pmRNSHolding(s) in Company
23rd May 20237:30 amRNSRestoration - Pressure Technologies plc
23rd May 20237:05 amRNSConfirmation of Board Appointments
23rd May 20237:00 amRNS2022 Full-Year Results
27th Apr 202310:30 amRNSFurther Update on FY22 Annual Report & Accounts
3rd Apr 20237:30 amRNSSuspension - Pressure Technologies plc
31st Mar 20231:56 pmRNSResult of AGM
27th Mar 20237:05 amRNSMajor Order Placement
27th Mar 20237:00 amRNSUpdate on Annual Report and Accounts
21st Mar 20237:05 amRNSBoard Appointments
21st Mar 20237:00 amRNSUpdate on FY22 Audit, AGM & Current Trading
7th Mar 20237:00 amRNSNotice of AGM
6th Feb 20237:00 amRNSContract
17th Jan 20237:00 amRNSAppointment of Chief Financial Officer
21st Dec 202211:57 amRNSHolding(s) in Company
8th Dec 20227:58 amRNSHolding(s) in Company
7th Dec 20221:44 pmRNSHolding(s) in Company
2nd Dec 20221:20 pmRNSResult of General Meeting
15th Nov 20223:18 pmRNSRESULT OF PLACING AND RETAIL OFFER
15th Nov 20227:01 amRNSREX Retail Offer
15th Nov 20227:00 amRNSPROPOSED PLACING AND RETAIL OFFER
5th Oct 202210:26 amRNSHolding(s) in Company
4th Oct 202210:37 amRNSHolding(s) in Company
3rd Oct 202212:38 pmRNSHolding(s) in Company
30th Sep 20224:47 pmRNSHolding(s) in Company
29th Sep 20225:31 pmRNSHolding(s) in Company
29th Sep 20222:05 pmRNSSecond Price Monitoring Extn
29th Sep 20222:00 pmRNSPrice Monitoring Extension
28th Sep 20225:02 pmRNSHolding(s) in Company
28th Sep 20224:41 pmRNSSecond Price Monitoring Extn
28th Sep 20224:35 pmRNSPrice Monitoring Extension
27th Sep 20224:40 pmRNSSecond Price Monitoring Extn
27th Sep 20224:35 pmRNSPrice Monitoring Extension
27th Sep 20222:06 pmRNSSecond Price Monitoring Extn
27th Sep 20222:00 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.